Frequently Asked Questions

Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.

1. CPK-MB

High CPK-MB levels typically indicate heart muscle damage, such as from a heart attack.

Yes, certain medications can influence CPK-MB levels. It’s important to inform your healthcare provider about all medications you are taking.

No, fasting is not required for the CPK-MB test unless specified by your healthcare provider.

The frequency of testing depends on your health condition and your healthcare provider’s recommendations.

Abnormal CPK-MB levels may indicate heart muscle damage. Further evaluation and treatment will be necessary based on your test results.

2. HBSAG SPOT

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease.

Anyone at risk of hepatitis B exposure or needing routine screening should undergo this test. This includes individuals with potential exposure through sexual contact, blood transfusions, or needle-sharing.

Yes, the HBSAg Spot Test is highly accurate in detecting hepatitis B surface antigen. However, a positive result requires confirmation through additional tests.

No, additional tests are needed to differentiate between acute and chronic hepatitis B infection.

A positive result indicates possible hepatitis B infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.

3. HIV ( ELISA )

The test detects antibodies against HIV, indicating a possible infection.

The test can typically detect HIV antibodies within 2-12 weeks after exposure.

A positive result will be followed by confirmatory tests to validate the diagnosis.

Yes, test results are confidential and shared only with you and your healthcare provider.